Correlation Between Health Care and Evaluator Growth

Can any of the company-specific risk be diversified away by investing in both Health Care and Evaluator Growth at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Health Care and Evaluator Growth into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Health Care Ultrasector and Evaluator Growth Rms, you can compare the effects of market volatilities on Health Care and Evaluator Growth and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Health Care with a short position of Evaluator Growth. Check out your portfolio center. Please also check ongoing floating volatility patterns of Health Care and Evaluator Growth.

Diversification Opportunities for Health Care and Evaluator Growth

0.22

Correlation Coefficient

Health Care  Evaluator Growth

Modest diversification

The 3 months correlation between Health and Evaluator is 0.22. Overlapping area represents the amount of risk that can be diversified away by holding Health Care Ultrasector and Evaluator Growth Rms in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Evaluator Growth Rms and Health Care is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Health Care Ultrasector are associated (or correlated) with Evaluator Growth. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Evaluator Growth Rms has no effect on the direction of Health Care i.e., Health Care and Evaluator Growth go up and down completely randomly.

Pair Corralation between Health Care and Evaluator Growth

Assuming the 90 days horizon Health Care Ultrasector is expected to generate 2.76 times more return on investment than Evaluator Growth. However, Health Care is 2.76 times more volatile than Evaluator Growth Rms. It trades about 0.08 of its potential returns per unit of risk. Evaluator Growth Rms is currently generating about 0.2 per unit of risk. If you would invest  9,063  in Health Care Ultrasector on May 25, 2025 and sell it today you would earn a total of  572.00  from holding Health Care Ultrasector or generate 6.31% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Health Care Ultrasector  vs.  Evaluator Growth Rms

Health Care Ultrasector

Risk-Adjusted Performance

Mild

Compared to the overall equity markets, risk-adjusted returns on investments in Health Care Ultrasector are ranked lower than 6 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak forward indicators, Health Care may actually be approaching a critical reversion point that can send shares even higher in September 2025.

Evaluator Growth Rms

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Evaluator Growth Rms are ranked lower than 15 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong essential indicators, Evaluator Growth is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Health Care and Evaluator Growth

The main advantage of trading using opposite Health Care and Evaluator Growth positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Health Care position performs unexpectedly, Evaluator Growth can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evaluator Growth will offset losses from the drop in Evaluator Growth's long position.

The idea behind Health Care Ultrasector and Evaluator Growth Rms pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..